Oligometastatic Prostate Cancer clinical trials

Explore recruiting oligometastatic prostate cancer clinical trials.

Recruiting oligometastatic prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oligometastatic Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An International, Prospective, Open-label, Multi-center, Randomized Phase III Study comparing lutetium (177Lu) vipivotide tetraxetan (AAA617) versus Observation to delay castration or disease recurrence in adult male patients with prostate-specific membrane antigen (PSMA) positive Oligometastatic Prostate Cancer (OMPC)

France, Czechia, Spain, Belgium, Italy, Slovakia +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neoadjuvant [177Lu]Lu-PSMAI&T radioligand therapy (PSMA-RLT) for patients with oligometastatic prostate cancer diagnosed using [68Ga]Ga-PSMA-11 PET imaging followed by radical prostatectomy: A Prospective Phase II Pilot Study

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase II randomized trial of Lu-PSMA and Stereotactic Radiotherapy versus Radiotherapy alone for oligometastatic prostate cancer (LUST)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Oligometastatic Prostate Cancer trials by city

Oligometastatic Prostate Cancer in Toronto Oligometastatic Prostate Cancer in Vancouver Oligometastatic Prostate Cancer in Montreal Oligometastatic Prostate Cancer in Calgary Oligometastatic Prostate Cancer in Edmonton Oligometastatic Prostate Cancer in Ottawa Oligometastatic Prostate Cancer in Winnipeg Oligometastatic Prostate Cancer in Quebec City Oligometastatic Prostate Cancer in Hamilton Oligometastatic Prostate Cancer in Kitchener Oligometastatic Prostate Cancer in London Oligometastatic Prostate Cancer in Halifax Oligometastatic Prostate Cancer in New York Oligometastatic Prostate Cancer in Los Angeles Oligometastatic Prostate Cancer in Chicago Oligometastatic Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease